Novartis receives positive CHMP opinion for Leqvio®* (inclisiran), a potential first-in-class siRNA for the treatment of high cholesterol

Stacey Gandler
Brand Nourishment

Joey Cohen
Medication Adherence

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

Matt Turner
Patient Affordability

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

David Linetsky
Point-of-Care Marketing

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Frank Burrell
Scientific Storytelling